Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review

In clinical use, bevacizumab has improved the overall survival (OS) and progression-free survival (PFS) of malignant solid tumors, and the safe use of bevacizumab has gradually become the mainstream direction of clinical, nursing and pharmaceutical research. Bevacizumab is a humanized anti-VEGF drug...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ke Chen, Boyang Jiang, Huiping Yan, Liu Yang, Zheling Chen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-02-01
Σειρά:	Frontiers in Oncology
Θέματα:	bevacizumab adverts effects VEGF cerebrovascular accident cancer case report
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1395129/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!